SlideShare una empresa de Scribd logo
1 de 34
Descargar para leer sin conexión
D R . H A R S H S A X E N A
J R 2 M E D I C I N E
S R M S I M S
Sub clinical thyroid dysfunction
Introduction
 The term subclinical denotes the presence of a disease
without obvious symptoms, which means that evolution of
the disease might be at an early stage.
 Subclinical thyroid disease is defined as biochemically,
subclinical hyperthyroidism occurs when serum thyroid-
stimulating hormone (TSH) concentrations are low or
undetectable but free thyroxine (T4) and tri-iodothyronine
(T3) concentrations are normal.
 Subclinical hypothyroidism occurs when serum TSH
concentrations are raised and serum thyroid hormone
concentrations are normal.
Subclinical
hyperthyroidism
Subclinical
hypothyroidism
Subclinical hyperthyroidism
 Subclinical hyperthyroidism is a form of hyperthyroidism,
in which TSH progressively decreases indicating worsening
thyroid overactivity.
 Exogenous disease caused intentionally or unintentionally by
thyroid hormone therapy.
 Endogenous disease caused by conditions responsible for
most forms of overt hyperthyroidism.
Classification of subclinical hyperthyroidism and
other low serum TSH
 Causes of persistent subclinical hyperthyroidism:
 1) Exogenous: Iatrogenic (intentional or unintentional).
 2) Endogenous :Toxic multinodular goitre, Solitary toxic
nodule (solitary autonomous nodule),Grave’s disease.
Causes of transient subclinical
hyperthyroidism
1) Treatment of overt hyperthyroidism with antithyroid drugs
or radioiodine.
2) Evolution of various forms of thyroiditis, subacute
thyroiditis (viral or DeQuervain's),
silent thyroiditis (painless thyroiditis),
amiodarone-induced thyrotoxicosis (amiodarone-induced
thyroiditis.
Causes of low serum TSH concentrations
that are not subclinical hyperthyroidism:
1)Low serum TSH at end of the first trimester of pregnancy.
2)Low serum TSH in severe non-thyroidal illness and with
treatment with high-dose glucocorticoids.
3)Low serum TSH seen in some elderly individuals without
apparent thyroid disease.
4)Low serum TSH seen in smoker.
Symptoms
 Young and middle aged patients with subclinical
hyperthyroidism can present with:
 1)Palpitations
 2)Heat intolerance
 3)Anxiety
 Elderly people has been associated with dementia.
 Patients with subclinical disease have a higher mean 24-h
heart rate than in a euthyroid state and have an increased
frequency of premature atrial and ventricular beats.
 Patients with subclinical hyperthyroidism had increased
carotid intima-media thickness compared with individuals in
a euthyroid state.
 Patients with subclinical hyperthyroidism also had an
increased frequency of carotid artery plaques and stroke,
especially in elderly patients or in those with underlying
cardiac disease.
 Thyroid hormone stimulates bone resorption by a direct
effect on osteoclast function.
 Overt hyperthyroidism is associated with increased bone
turnover and an increased risk of osteoporosis and
fracture.
Diagnosis
 Subclinical hyperthyroidism occurs when the serum TSH is
below the lower limit of the reference range and the free T4
and T3 concentrations are normal.
 Some healthy elderly people might have low serum TSH
without identifiable thyroid disease that can be due to a
change in the set point of the hypothalamic-pituitary-thyroid
axis with ageing.
 Graves' disease is the most common cause of subclinical
hyperthyroidism in young patients, whereas toxic multinodular
goitre and solitary autonomous nodules are more common
with ageing.
 Serum TSH will be less than 0·2 mU/L in up to 18% of
pregnant women, most of whom will have normal free T4
concentrations.
 In the euthyroid sick syndrome, the serum free T4 and T3
concentrations are typically low and TSH might also be
subnormal.
Laboratory testing
 Thyroid imaging should be done in cases with persistently low
serum TSH concentrations, especially those with less than 0·1
mU/L.
 Radionuclide thyroid scanning with either 123I or 99mTc.
 Colour-flow doppler sonography can reveal the presence of a
multinodular goitre or a pattern suggestive of autoimmune
disease.
 Measurements of anti-thyroid antibodies especially antithyroid
peroxidase antibodies and anti-TSH receptor antibodies
should be done in patients with suspected Graves' disease.
 Fine-needle biopsy should be considered in patients with
suspicious nodules by sonography.
 In postmenopausal women assessment of bone mineral
density should be considered, as the presence of
osteoporosis would favour treatment.
 Anticoagulation should be considered if atrial fibrillation is
present.
Treatment of patients with serum TSH
concentrations of less than 0·1 mU/L
 In patients older than 65 years who have low serum TSH
concentrations secondary to toxic multinodular goitre or a
solitary autonomous solitary nodule, radioactive iodine is a
definitive and preferred form of treatment because
spontaneous remission is unlikely to occur.
 In patients with Graves' disease, treatment with either
antithyroid drugs or radioiodine is done.
 Reasonable alternatives as β-adrenergic-blocking drug in
patients at risk for atrial fibrillation, calcium supplementation
and treatment with a bisphosphonate in postmenopausal
women with osteoporosis.
In asymptomatic patients younger than 65 years who do not
have cardiac risk factors or in premenopausal women, no
evidence is available for benefit of treatment.
 Patients with toxic multinodular goitre or solitary toxic
adenomas, have a risk of progression to overt
hyperthyroidism, so that treatment with radioactive iodine
should be considered.
 Surgery would be an option in patients with subclinical
hyperthyroidism and compressive symptoms from a large
goitre.
 Untreated patients need follow-up of thyroid function every 6-
12 months.
Treatment of patients with serum TSH
concentrations of 0·1—0·4 mU/L
 Patients whose serum TSH concentrations are only minimally
suppressed might not need treatment.
 Some patients regain normal thyroid function whereas others
progress.
 In patients older than 65 years, a 12-month course of
treatment should be considered in patients with Graves'
disease antithyroid drugs or radioactive iodine therapy in
those with nodular thyroid disease.
Sub clinical thyroid dysfunction
Subclinical hypothyroidism
 Dependent on the size of the increase in serum TSH, subclinical
hypothyroidism can be mild (serum TSH concentrations of 4·5-9
mU/L) or severe (TSH ≥10 mU/L).
 At least 75% of patients with subclinical disease have mild
thyroid dysfunction (TSH ≤10 mU/L).
 In about 60-80% the disorder is associated with antithyroid
peroxidase antibodies, chronic lymphocytic (Hashimoto's)
thyroiditis.
 Hashimoto's thyroiditis is more common in girls and women,
and the overall incidence increases with age in both sexes.
Causes of persistent subclinical
hypothyroidism
 Chronic autoimmune thyroiditis.
 Partial thyroidectomy.
 Radioactive iodine therapy for treatment of
hyperthyroidism
 External radiotherapy of the head and neck in patients
with Hodgkin's lymphoma, leukaemia, aplastic anaemia,
brain tumours, or bone-marrow transplantation.
 Infiltrative disorders of the thyroid gland ( amyloidosis,
sarcoidosis, haemochromatosis, or Riedel's thyroiditis.
 Persistent TSH increase after an episode of subacute
thyroiditis, post-partum thyroiditis.
 Drugs impairing thyroid function in patients with autoimmune
thyroiditis (iodine and iodine-containing drugs, amiodarone)
and radiographic contrast agents, lithium carbonate,
cytokines especially interferon alfa.
 Inadequate replacement therapy for overt hypothyroidism
inadequate dose, non-compliance, drug interactions,
increased T4 clearance , malabsorption ,toxic substances,
industrial, and environmental agents.
 Thyroid dysgenesis
 Iodine deficiency
Causes of physiological or transient
increases in serum TSH concentrations
 Diurnal variation with a nocturnal surge and highest
values early in the morning.
 Recovery phase from non-thyroidal illness.
 After withdrawal of thyroid hormone therapy in
patients in a euthyroid state.
 Transient subclinical hypothyroidism after subacute,
painless, or post-partum thyroiditis.
Causes of increased serum TSH
concentrations that are not subclinical
hypothyroidism
 Elderly patients with small increases in serum TSH
concentrations
 Obesity
 TSH-secreting pituitary adenoma
 Isolated pituitary resistance to thyroid hormone
 TSH with reduced biological activity
 Impaired renal function
 Untreated adrenal insufficiency
Symptoms
 May be asymptomatic and vague complaints including fatigue
,depression ,anxiety,weakness ,sleep disturbance ,memory
problems,constipation,menstrual irregularities.
 Subclinical hypothyroidism seems to be less symptomatic in
elderly people.
 May have no physical abnormalities can have skin/hair
Changes ,reflex delay, ataxia,hyperlipidemia,nonpitting edema,
hoarseness, bradycardia, hypothermia.
 Patients with subclinical hypothyroidism can have depressed
systolic function at rest, and left ventricular diastolic
dysfunction at rest and during exercise.
 Patients have diastolic hypertension, hypercholesterolaemia
,insulin resistance, weight gain ,and isolated diastolic
dysfunction.
Women of reproductive age and
during pregnancy
 The prevalence of subclinical hypothyroidism in women during
reproductive age is 0·5—5%.
 Maternal subclinical hypothyroidism can lead to serious
obstetric complications, including an increased risk of
miscarriage, placental abruption, preterm delivery, gestational
hypertension and low birthweight.
 Thyroid hormone is essential for fetal brain development and
maturation.
 Maternal transfer of thyroid hormone is essential, especially
during the first trimester of pregnancy, as the fetal thyroid gland
does not produce thyroid hormone until about 13 weeks of
gestation.
Patients with serum TSH concentrations
of 3—4·5 mU/L
 Patients with serum TSH concentrations can have increased
rates of progression to overt hypothyroidism, so they should be
monitored with periodic thyroid function tests, especially if they
have positive antithyroid peroxidase antibodies.
 During pregnancy, serum TSH concentrations of more than 2·5
mU/L during the first trimester and of 3·1-3·5 mU/L during the
second trimester are probably indicative of mild
hypothyroidism.
 Pregnant women should be treated if they have TSH
concentrations at the upper limit of the normal range for
women who are not pregnant.
 Women in a euthyroid state who have autoimmune thyroiditis
in early gestation should be monitored during pregnancy for
raised serum TSH concentrations during pregnancy.
Patients with mild subclinical
hypothyroidism, with serum TSH
concentrations of 5—9 mU/L
 Subclinical hypothyroidism might be associated with
greater cardiovascular risk in young and middle-aged
people than in people older than 65 years.
 Patients with new onset of symptoms, depression, goitre,
positive antithyroid antibody tests or cardiovascular risk
factors hypertension, hypercholesterolaemia, insulin
resistance or diabetes, or isolated diastolic dysfunction
benefit from treatment.
 If levothyroxine replacement has a beneficial effect,
treatment should be continued and serum TSH
concentrations should be assessed every 6-12 months to
ensure that they remain within the normal range.
 Treatment might be reduced in patients older than
65 years with serum TSH concentrations of 4·5-10
mU/L.
 Levothyroxine treatment is started, low doses (25—
50 μg/day) should be used in patients with known
coronary artery disease.
Patients with subclinical
hypothyroidism with serum TSH
concentrations of 10 mU/L or higher
 Patients with high TSH concentrations have a significantly
increased risk of progression to overt hypothyroidism, have
an increased chances of cardiovascular disease.
 Replacement therapy should be individualised in elderly
and very elderly patients with serum TSH concentrations of
more than 10 mU/L.
 Low doses of levothyroxine are often adequate to
normalise serum TSH concentrations in elderly patients.
 Over-treatment with levothyroxine should be avoided
because of the adverse cardiovascular and skeletal
consequences of iatrogenic hyperthyroidism in elderly
people.
Sub clinical thyroid dysfunction
Conclusions
 Subclinical thyroid disease is a common clinical problem and
since most patients are asymptomatic, screening is the only
way that most patients with the condition will be detected.
 Recommend treatment of individuals with subclinical
hyperthyroidism who are older than 65 years of age with
serum TSH concentrations less than 0·1 mU/L.
 Subclinical hypothyroidism who have serum TSH
concentrations of 10 mU/L or more.
 Pregnant women with serum TSH concentrations that are
above the reference range for pregnancy.
 Patients who have more mildly low or high serum TSH
concentrations in between the extremes (ie, 0·1-0·5 mU/L
and 5·0-10·0 mU/L), no firm recommendations and the
decision to treat or not to treat a patient is based on various
clinical factors.
References
 The Lancet, Volume 379, Issue 9821, Pages 1142 - 1154,
24 March 2012.
 Harrisons 18th edition volume 2 pages 2911-2935.
 Williams Textbook of Endocrinology,12th edition.
Sub clinical thyroid dysfunction

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Hyperthyroidism
HyperthyroidismHyperthyroidism
Hyperthyroidism
 
Subclinical hypothyroidism
Subclinical hypothyroidismSubclinical hypothyroidism
Subclinical hypothyroidism
 
Thyrotoxicosis
ThyrotoxicosisThyrotoxicosis
Thyrotoxicosis
 
Thyrotoxicosis
ThyrotoxicosisThyrotoxicosis
Thyrotoxicosis
 
Hyperthyroidism approach to management- dr selim
Hyperthyroidism approach to management- dr selimHyperthyroidism approach to management- dr selim
Hyperthyroidism approach to management- dr selim
 
Graves Disease
Graves DiseaseGraves Disease
Graves Disease
 
Hyperthyroidism
HyperthyroidismHyperthyroidism
Hyperthyroidism
 
Myxedema coma
Myxedema comaMyxedema coma
Myxedema coma
 
Hypothyroidism --a clinical perspective
Hypothyroidism --a clinical perspectiveHypothyroidism --a clinical perspective
Hypothyroidism --a clinical perspective
 
Hyperthyroidism
HyperthyroidismHyperthyroidism
Hyperthyroidism
 
Thyroid disorders
Thyroid disordersThyroid disorders
Thyroid disorders
 
2nd wk of endocrine FT
2nd wk of endocrine FT2nd wk of endocrine FT
2nd wk of endocrine FT
 
Hyperparathyroidism & Hypoparathyroidism
Hyperparathyroidism & HypoparathyroidismHyperparathyroidism & Hypoparathyroidism
Hyperparathyroidism & Hypoparathyroidism
 
Acromegaly - Clinical Round
Acromegaly - Clinical RoundAcromegaly - Clinical Round
Acromegaly - Clinical Round
 
Hyperthyroidism-2022.pptx
Hyperthyroidism-2022.pptxHyperthyroidism-2022.pptx
Hyperthyroidism-2022.pptx
 
Hyperthyroidism
HyperthyroidismHyperthyroidism
Hyperthyroidism
 
Thyroid
ThyroidThyroid
Thyroid
 
Refeeding syndrome
Refeeding syndromeRefeeding syndrome
Refeeding syndrome
 
An approach to a patient with chronic diarrhea
An approach to a patient with chronic diarrhea An approach to a patient with chronic diarrhea
An approach to a patient with chronic diarrhea
 
Hypothyrodism
HypothyrodismHypothyrodism
Hypothyrodism
 

Destacado

Subclinical hypothyroidism in pregnancy
Subclinical hypothyroidism in pregnancySubclinical hypothyroidism in pregnancy
Subclinical hypothyroidism in pregnancyDilek Gogas Yavuz
 
HYPOTHYROIDIM Made Easy –Through Case Studies, Dr. Sharda jain
HYPOTHYROIDIM Made Easy –Through  Case Studies, Dr. Sharda jain HYPOTHYROIDIM Made Easy –Through  Case Studies, Dr. Sharda jain
HYPOTHYROIDIM Made Easy –Through Case Studies, Dr. Sharda jain Lifecare Centre
 
management of Hyperthyroidism
management of Hyperthyroidism  management of Hyperthyroidism
management of Hyperthyroidism Zelalem Semegnew
 
subclinical hypothyrodism
subclinical hypothyrodismsubclinical hypothyrodism
subclinical hypothyrodismYassin Alsaleh
 
Thyroid disorders in pregnancy
Thyroid disorders in pregnancyThyroid disorders in pregnancy
Thyroid disorders in pregnancyajay dhawle
 
Diabetes Mellitus and Fasting Ramadan may 2015
Diabetes Mellitus  and Fasting Ramadan may 2015Diabetes Mellitus  and Fasting Ramadan may 2015
Diabetes Mellitus and Fasting Ramadan may 2015Mohammad Othman Daoud
 
Hipertireoidismo e hipotireoidismo
Hipertireoidismo e hipotireoidismoHipertireoidismo e hipotireoidismo
Hipertireoidismo e hipotireoidismoWalquer Sobrinho
 
Hiper e hipotireoidismo
Hiper e hipotireoidismoHiper e hipotireoidismo
Hiper e hipotireoidismoEdienny Viana
 

Destacado (12)

Subclinical hypothyroidism in pregnancy
Subclinical hypothyroidism in pregnancySubclinical hypothyroidism in pregnancy
Subclinical hypothyroidism in pregnancy
 
Starting Insulin by M Daoud
Starting Insulin by M DaoudStarting Insulin by M Daoud
Starting Insulin by M Daoud
 
HYPOTHYROIDIM Made Easy –Through Case Studies, Dr. Sharda jain
HYPOTHYROIDIM Made Easy –Through  Case Studies, Dr. Sharda jain HYPOTHYROIDIM Made Easy –Through  Case Studies, Dr. Sharda jain
HYPOTHYROIDIM Made Easy –Through Case Studies, Dr. Sharda jain
 
Hypothyroidism
HypothyroidismHypothyroidism
Hypothyroidism
 
management of Hyperthyroidism
management of Hyperthyroidism  management of Hyperthyroidism
management of Hyperthyroidism
 
subclinical hypothyrodism
subclinical hypothyrodismsubclinical hypothyrodism
subclinical hypothyrodism
 
Incretins based therapy :How Early
Incretins based therapy :How EarlyIncretins based therapy :How Early
Incretins based therapy :How Early
 
Thyroid disorders in pregnancy
Thyroid disorders in pregnancyThyroid disorders in pregnancy
Thyroid disorders in pregnancy
 
Diabetes Mellitus and Fasting Ramadan may 2015
Diabetes Mellitus  and Fasting Ramadan may 2015Diabetes Mellitus  and Fasting Ramadan may 2015
Diabetes Mellitus and Fasting Ramadan may 2015
 
Hipertireoidismo e hipotireoidismo
Hipertireoidismo e hipotireoidismoHipertireoidismo e hipotireoidismo
Hipertireoidismo e hipotireoidismo
 
Hiper e hipotireoidismo
Hiper e hipotireoidismoHiper e hipotireoidismo
Hiper e hipotireoidismo
 
Hypothyroidism
HypothyroidismHypothyroidism
Hypothyroidism
 

Similar a Sub clinical thyroid dysfunction

2012 Clinical Practice guidelines for hypothyroidism in adults: American Asso...
2012 Clinical Practice guidelines for hypothyroidism in adults: American Asso...2012 Clinical Practice guidelines for hypothyroidism in adults: American Asso...
2012 Clinical Practice guidelines for hypothyroidism in adults: American Asso...Jibran Mohsin
 
Anesthesia: Thyroid and Parathyroid
Anesthesia: Thyroid and ParathyroidAnesthesia: Thyroid and Parathyroid
Anesthesia: Thyroid and ParathyroidBashar Mudallal
 
Hypothyroidism and Hyperthyroidism
Hypothyroidism and HyperthyroidismHypothyroidism and Hyperthyroidism
Hypothyroidism and HyperthyroidismMedicineAndFamily
 
Interpretation of laboratory thyroid function tests
Interpretation of laboratory thyroid function tests Interpretation of laboratory thyroid function tests
Interpretation of laboratory thyroid function tests Hussam Elmouzi
 
Thyroid storm
Thyroid stormThyroid storm
Thyroid stormdocgeero
 
11.hypo and hyperthyroidism ppt
11.hypo and hyperthyroidism ppt11.hypo and hyperthyroidism ppt
11.hypo and hyperthyroidism pptPoojaDagar3
 
Diagnosis and treatment of hypothyroidism.pptx
Diagnosis and treatment of hypothyroidism.pptxDiagnosis and treatment of hypothyroidism.pptx
Diagnosis and treatment of hypothyroidism.pptxvivianOkoli1
 
Thyroid disease, hypo & hyper thyrodisim
Thyroid disease, hypo & hyper thyrodisimThyroid disease, hypo & hyper thyrodisim
Thyroid disease, hypo & hyper thyrodisimSara Fahad
 
2727_Management of Thyroid Disorders.ppt
2727_Management of Thyroid Disorders.ppt2727_Management of Thyroid Disorders.ppt
2727_Management of Thyroid Disorders.pptibrahimosman57
 
Thyroid disease in dental
Thyroid disease in dentalThyroid disease in dental
Thyroid disease in dentalMary Nasr
 
Thyroid Overview
Thyroid OverviewThyroid Overview
Thyroid OverviewMiami Dade
 
Anaesthetic mgt for pt with hyperthyroidism pritam
Anaesthetic mgt for pt with hyperthyroidism  pritamAnaesthetic mgt for pt with hyperthyroidism  pritam
Anaesthetic mgt for pt with hyperthyroidism pritamhavalprit
 

Similar a Sub clinical thyroid dysfunction (20)

2012 Clinical Practice guidelines for hypothyroidism in adults: American Asso...
2012 Clinical Practice guidelines for hypothyroidism in adults: American Asso...2012 Clinical Practice guidelines for hypothyroidism in adults: American Asso...
2012 Clinical Practice guidelines for hypothyroidism in adults: American Asso...
 
Thyroid
ThyroidThyroid
Thyroid
 
Anesthesia: Thyroid and Parathyroid
Anesthesia: Thyroid and ParathyroidAnesthesia: Thyroid and Parathyroid
Anesthesia: Thyroid and Parathyroid
 
Hypothyroidism and Hyperthyroidism
Hypothyroidism and HyperthyroidismHypothyroidism and Hyperthyroidism
Hypothyroidism and Hyperthyroidism
 
Pharmacotherapy thyroid disorders
Pharmacotherapy thyroid disordersPharmacotherapy thyroid disorders
Pharmacotherapy thyroid disorders
 
Hypothyrodism
HypothyrodismHypothyrodism
Hypothyrodism
 
Hypothyroidism
HypothyroidismHypothyroidism
Hypothyroidism
 
Interpretation of laboratory thyroid function tests
Interpretation of laboratory thyroid function tests Interpretation of laboratory thyroid function tests
Interpretation of laboratory thyroid function tests
 
Thyroid storm
Thyroid stormThyroid storm
Thyroid storm
 
11.hypo and hyperthyroidism ppt
11.hypo and hyperthyroidism ppt11.hypo and hyperthyroidism ppt
11.hypo and hyperthyroidism ppt
 
Thyroidstorm ppt
Thyroidstorm pptThyroidstorm ppt
Thyroidstorm ppt
 
Hyperthyroidism.pptx
Hyperthyroidism.pptxHyperthyroidism.pptx
Hyperthyroidism.pptx
 
Hypothyroidism
HypothyroidismHypothyroidism
Hypothyroidism
 
Diagnosis and treatment of hypothyroidism.pptx
Diagnosis and treatment of hypothyroidism.pptxDiagnosis and treatment of hypothyroidism.pptx
Diagnosis and treatment of hypothyroidism.pptx
 
Thyroid disease, hypo & hyper thyrodisim
Thyroid disease, hypo & hyper thyrodisimThyroid disease, hypo & hyper thyrodisim
Thyroid disease, hypo & hyper thyrodisim
 
2727_Management of Thyroid Disorders.ppt
2727_Management of Thyroid Disorders.ppt2727_Management of Thyroid Disorders.ppt
2727_Management of Thyroid Disorders.ppt
 
hyperthyroidism in ksa
hyperthyroidism in ksahyperthyroidism in ksa
hyperthyroidism in ksa
 
Thyroid disease in dental
Thyroid disease in dentalThyroid disease in dental
Thyroid disease in dental
 
Thyroid Overview
Thyroid OverviewThyroid Overview
Thyroid Overview
 
Anaesthetic mgt for pt with hyperthyroidism pritam
Anaesthetic mgt for pt with hyperthyroidism  pritamAnaesthetic mgt for pt with hyperthyroidism  pritam
Anaesthetic mgt for pt with hyperthyroidism pritam
 

Más de DrHarsh Saxena

AKI IN CIRRHOSIS 1.pptx
AKI IN CIRRHOSIS 1.pptxAKI IN CIRRHOSIS 1.pptx
AKI IN CIRRHOSIS 1.pptxDrHarsh Saxena
 
Burden of liver disease progression in hospitalized patients JOURNAL 2.pptx
Burden of liver disease progression in hospitalized patients JOURNAL 2.pptxBurden of liver disease progression in hospitalized patients JOURNAL 2.pptx
Burden of liver disease progression in hospitalized patients JOURNAL 2.pptxDrHarsh Saxena
 
A pilot study of golexanolone, a new.pptx
A pilot study of golexanolone, a new.pptxA pilot study of golexanolone, a new.pptx
A pilot study of golexanolone, a new.pptxDrHarsh Saxena
 
Obstructive Jaundice presentaion harsh.pptx
Obstructive Jaundice presentaion harsh.pptxObstructive Jaundice presentaion harsh.pptx
Obstructive Jaundice presentaion harsh.pptxDrHarsh Saxena
 
ABG in liver disease.pptx
ABG in liver disease.pptxABG in liver disease.pptx
ABG in liver disease.pptxDrHarsh Saxena
 
Viral hepatitis Elimination challenges and progress Final.pptx
Viral hepatitis Elimination challenges and progress Final.pptxViral hepatitis Elimination challenges and progress Final.pptx
Viral hepatitis Elimination challenges and progress Final.pptxDrHarsh Saxena
 
The acute abdomen seminar
The acute abdomen seminarThe acute abdomen seminar
The acute abdomen seminarDrHarsh Saxena
 
Liverdiseaseinpregnancy2 090429102624-phpapp01
Liverdiseaseinpregnancy2 090429102624-phpapp01Liverdiseaseinpregnancy2 090429102624-phpapp01
Liverdiseaseinpregnancy2 090429102624-phpapp01DrHarsh Saxena
 
Nutritional therapy in systemic diseases
Nutritional therapy in systemic diseasesNutritional therapy in systemic diseases
Nutritional therapy in systemic diseasesDrHarsh Saxena
 

Más de DrHarsh Saxena (14)

HEAL JC.pptx
HEAL JC.pptxHEAL JC.pptx
HEAL JC.pptx
 
AUDIT
AUDITAUDIT
AUDIT
 
AKI IN CIRRHOSIS 1.pptx
AKI IN CIRRHOSIS 1.pptxAKI IN CIRRHOSIS 1.pptx
AKI IN CIRRHOSIS 1.pptx
 
Burden of liver disease progression in hospitalized patients JOURNAL 2.pptx
Burden of liver disease progression in hospitalized patients JOURNAL 2.pptxBurden of liver disease progression in hospitalized patients JOURNAL 2.pptx
Burden of liver disease progression in hospitalized patients JOURNAL 2.pptx
 
A pilot study of golexanolone, a new.pptx
A pilot study of golexanolone, a new.pptxA pilot study of golexanolone, a new.pptx
A pilot study of golexanolone, a new.pptx
 
Obstructive Jaundice presentaion harsh.pptx
Obstructive Jaundice presentaion harsh.pptxObstructive Jaundice presentaion harsh.pptx
Obstructive Jaundice presentaion harsh.pptx
 
baveno 7.pptx
baveno 7.pptxbaveno 7.pptx
baveno 7.pptx
 
ABG in liver disease.pptx
ABG in liver disease.pptxABG in liver disease.pptx
ABG in liver disease.pptx
 
HISTORY HE.pptx
HISTORY HE.pptxHISTORY HE.pptx
HISTORY HE.pptx
 
Viral hepatitis Elimination challenges and progress Final.pptx
Viral hepatitis Elimination challenges and progress Final.pptxViral hepatitis Elimination challenges and progress Final.pptx
Viral hepatitis Elimination challenges and progress Final.pptx
 
he esld.pdf
he esld.pdfhe esld.pdf
he esld.pdf
 
The acute abdomen seminar
The acute abdomen seminarThe acute abdomen seminar
The acute abdomen seminar
 
Liverdiseaseinpregnancy2 090429102624-phpapp01
Liverdiseaseinpregnancy2 090429102624-phpapp01Liverdiseaseinpregnancy2 090429102624-phpapp01
Liverdiseaseinpregnancy2 090429102624-phpapp01
 
Nutritional therapy in systemic diseases
Nutritional therapy in systemic diseasesNutritional therapy in systemic diseases
Nutritional therapy in systemic diseases
 

Último

SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 

Último (20)

SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 

Sub clinical thyroid dysfunction

  • 1. D R . H A R S H S A X E N A J R 2 M E D I C I N E S R M S I M S Sub clinical thyroid dysfunction
  • 2. Introduction  The term subclinical denotes the presence of a disease without obvious symptoms, which means that evolution of the disease might be at an early stage.  Subclinical thyroid disease is defined as biochemically, subclinical hyperthyroidism occurs when serum thyroid- stimulating hormone (TSH) concentrations are low or undetectable but free thyroxine (T4) and tri-iodothyronine (T3) concentrations are normal.  Subclinical hypothyroidism occurs when serum TSH concentrations are raised and serum thyroid hormone concentrations are normal.
  • 4. Subclinical hyperthyroidism  Subclinical hyperthyroidism is a form of hyperthyroidism, in which TSH progressively decreases indicating worsening thyroid overactivity.  Exogenous disease caused intentionally or unintentionally by thyroid hormone therapy.  Endogenous disease caused by conditions responsible for most forms of overt hyperthyroidism.
  • 5. Classification of subclinical hyperthyroidism and other low serum TSH  Causes of persistent subclinical hyperthyroidism:  1) Exogenous: Iatrogenic (intentional or unintentional).  2) Endogenous :Toxic multinodular goitre, Solitary toxic nodule (solitary autonomous nodule),Grave’s disease.
  • 6. Causes of transient subclinical hyperthyroidism 1) Treatment of overt hyperthyroidism with antithyroid drugs or radioiodine. 2) Evolution of various forms of thyroiditis, subacute thyroiditis (viral or DeQuervain's), silent thyroiditis (painless thyroiditis), amiodarone-induced thyrotoxicosis (amiodarone-induced thyroiditis.
  • 7. Causes of low serum TSH concentrations that are not subclinical hyperthyroidism: 1)Low serum TSH at end of the first trimester of pregnancy. 2)Low serum TSH in severe non-thyroidal illness and with treatment with high-dose glucocorticoids. 3)Low serum TSH seen in some elderly individuals without apparent thyroid disease. 4)Low serum TSH seen in smoker.
  • 8. Symptoms  Young and middle aged patients with subclinical hyperthyroidism can present with:  1)Palpitations  2)Heat intolerance  3)Anxiety  Elderly people has been associated with dementia.
  • 9.  Patients with subclinical disease have a higher mean 24-h heart rate than in a euthyroid state and have an increased frequency of premature atrial and ventricular beats.  Patients with subclinical hyperthyroidism had increased carotid intima-media thickness compared with individuals in a euthyroid state.  Patients with subclinical hyperthyroidism also had an increased frequency of carotid artery plaques and stroke, especially in elderly patients or in those with underlying cardiac disease.
  • 10.  Thyroid hormone stimulates bone resorption by a direct effect on osteoclast function.  Overt hyperthyroidism is associated with increased bone turnover and an increased risk of osteoporosis and fracture.
  • 11. Diagnosis  Subclinical hyperthyroidism occurs when the serum TSH is below the lower limit of the reference range and the free T4 and T3 concentrations are normal.  Some healthy elderly people might have low serum TSH without identifiable thyroid disease that can be due to a change in the set point of the hypothalamic-pituitary-thyroid axis with ageing.  Graves' disease is the most common cause of subclinical hyperthyroidism in young patients, whereas toxic multinodular goitre and solitary autonomous nodules are more common with ageing.
  • 12.  Serum TSH will be less than 0·2 mU/L in up to 18% of pregnant women, most of whom will have normal free T4 concentrations.  In the euthyroid sick syndrome, the serum free T4 and T3 concentrations are typically low and TSH might also be subnormal.
  • 13. Laboratory testing  Thyroid imaging should be done in cases with persistently low serum TSH concentrations, especially those with less than 0·1 mU/L.  Radionuclide thyroid scanning with either 123I or 99mTc.  Colour-flow doppler sonography can reveal the presence of a multinodular goitre or a pattern suggestive of autoimmune disease.  Measurements of anti-thyroid antibodies especially antithyroid peroxidase antibodies and anti-TSH receptor antibodies should be done in patients with suspected Graves' disease.
  • 14.  Fine-needle biopsy should be considered in patients with suspicious nodules by sonography.  In postmenopausal women assessment of bone mineral density should be considered, as the presence of osteoporosis would favour treatment.  Anticoagulation should be considered if atrial fibrillation is present.
  • 15. Treatment of patients with serum TSH concentrations of less than 0·1 mU/L  In patients older than 65 years who have low serum TSH concentrations secondary to toxic multinodular goitre or a solitary autonomous solitary nodule, radioactive iodine is a definitive and preferred form of treatment because spontaneous remission is unlikely to occur.  In patients with Graves' disease, treatment with either antithyroid drugs or radioiodine is done.  Reasonable alternatives as β-adrenergic-blocking drug in patients at risk for atrial fibrillation, calcium supplementation and treatment with a bisphosphonate in postmenopausal women with osteoporosis.
  • 16. In asymptomatic patients younger than 65 years who do not have cardiac risk factors or in premenopausal women, no evidence is available for benefit of treatment.  Patients with toxic multinodular goitre or solitary toxic adenomas, have a risk of progression to overt hyperthyroidism, so that treatment with radioactive iodine should be considered.  Surgery would be an option in patients with subclinical hyperthyroidism and compressive symptoms from a large goitre.  Untreated patients need follow-up of thyroid function every 6- 12 months.
  • 17. Treatment of patients with serum TSH concentrations of 0·1—0·4 mU/L  Patients whose serum TSH concentrations are only minimally suppressed might not need treatment.  Some patients regain normal thyroid function whereas others progress.  In patients older than 65 years, a 12-month course of treatment should be considered in patients with Graves' disease antithyroid drugs or radioactive iodine therapy in those with nodular thyroid disease.
  • 19. Subclinical hypothyroidism  Dependent on the size of the increase in serum TSH, subclinical hypothyroidism can be mild (serum TSH concentrations of 4·5-9 mU/L) or severe (TSH ≥10 mU/L).  At least 75% of patients with subclinical disease have mild thyroid dysfunction (TSH ≤10 mU/L).  In about 60-80% the disorder is associated with antithyroid peroxidase antibodies, chronic lymphocytic (Hashimoto's) thyroiditis.  Hashimoto's thyroiditis is more common in girls and women, and the overall incidence increases with age in both sexes.
  • 20. Causes of persistent subclinical hypothyroidism  Chronic autoimmune thyroiditis.  Partial thyroidectomy.  Radioactive iodine therapy for treatment of hyperthyroidism  External radiotherapy of the head and neck in patients with Hodgkin's lymphoma, leukaemia, aplastic anaemia, brain tumours, or bone-marrow transplantation.  Infiltrative disorders of the thyroid gland ( amyloidosis, sarcoidosis, haemochromatosis, or Riedel's thyroiditis.  Persistent TSH increase after an episode of subacute thyroiditis, post-partum thyroiditis.
  • 21.  Drugs impairing thyroid function in patients with autoimmune thyroiditis (iodine and iodine-containing drugs, amiodarone) and radiographic contrast agents, lithium carbonate, cytokines especially interferon alfa.  Inadequate replacement therapy for overt hypothyroidism inadequate dose, non-compliance, drug interactions, increased T4 clearance , malabsorption ,toxic substances, industrial, and environmental agents.  Thyroid dysgenesis  Iodine deficiency
  • 22. Causes of physiological or transient increases in serum TSH concentrations  Diurnal variation with a nocturnal surge and highest values early in the morning.  Recovery phase from non-thyroidal illness.  After withdrawal of thyroid hormone therapy in patients in a euthyroid state.  Transient subclinical hypothyroidism after subacute, painless, or post-partum thyroiditis.
  • 23. Causes of increased serum TSH concentrations that are not subclinical hypothyroidism  Elderly patients with small increases in serum TSH concentrations  Obesity  TSH-secreting pituitary adenoma  Isolated pituitary resistance to thyroid hormone  TSH with reduced biological activity  Impaired renal function  Untreated adrenal insufficiency
  • 24. Symptoms  May be asymptomatic and vague complaints including fatigue ,depression ,anxiety,weakness ,sleep disturbance ,memory problems,constipation,menstrual irregularities.  Subclinical hypothyroidism seems to be less symptomatic in elderly people.  May have no physical abnormalities can have skin/hair Changes ,reflex delay, ataxia,hyperlipidemia,nonpitting edema, hoarseness, bradycardia, hypothermia.
  • 25.  Patients with subclinical hypothyroidism can have depressed systolic function at rest, and left ventricular diastolic dysfunction at rest and during exercise.  Patients have diastolic hypertension, hypercholesterolaemia ,insulin resistance, weight gain ,and isolated diastolic dysfunction.
  • 26. Women of reproductive age and during pregnancy  The prevalence of subclinical hypothyroidism in women during reproductive age is 0·5—5%.  Maternal subclinical hypothyroidism can lead to serious obstetric complications, including an increased risk of miscarriage, placental abruption, preterm delivery, gestational hypertension and low birthweight.  Thyroid hormone is essential for fetal brain development and maturation.  Maternal transfer of thyroid hormone is essential, especially during the first trimester of pregnancy, as the fetal thyroid gland does not produce thyroid hormone until about 13 weeks of gestation.
  • 27. Patients with serum TSH concentrations of 3—4·5 mU/L  Patients with serum TSH concentrations can have increased rates of progression to overt hypothyroidism, so they should be monitored with periodic thyroid function tests, especially if they have positive antithyroid peroxidase antibodies.  During pregnancy, serum TSH concentrations of more than 2·5 mU/L during the first trimester and of 3·1-3·5 mU/L during the second trimester are probably indicative of mild hypothyroidism.  Pregnant women should be treated if they have TSH concentrations at the upper limit of the normal range for women who are not pregnant.  Women in a euthyroid state who have autoimmune thyroiditis in early gestation should be monitored during pregnancy for raised serum TSH concentrations during pregnancy.
  • 28. Patients with mild subclinical hypothyroidism, with serum TSH concentrations of 5—9 mU/L  Subclinical hypothyroidism might be associated with greater cardiovascular risk in young and middle-aged people than in people older than 65 years.  Patients with new onset of symptoms, depression, goitre, positive antithyroid antibody tests or cardiovascular risk factors hypertension, hypercholesterolaemia, insulin resistance or diabetes, or isolated diastolic dysfunction benefit from treatment.  If levothyroxine replacement has a beneficial effect, treatment should be continued and serum TSH concentrations should be assessed every 6-12 months to ensure that they remain within the normal range.
  • 29.  Treatment might be reduced in patients older than 65 years with serum TSH concentrations of 4·5-10 mU/L.  Levothyroxine treatment is started, low doses (25— 50 μg/day) should be used in patients with known coronary artery disease.
  • 30. Patients with subclinical hypothyroidism with serum TSH concentrations of 10 mU/L or higher  Patients with high TSH concentrations have a significantly increased risk of progression to overt hypothyroidism, have an increased chances of cardiovascular disease.  Replacement therapy should be individualised in elderly and very elderly patients with serum TSH concentrations of more than 10 mU/L.  Low doses of levothyroxine are often adequate to normalise serum TSH concentrations in elderly patients.  Over-treatment with levothyroxine should be avoided because of the adverse cardiovascular and skeletal consequences of iatrogenic hyperthyroidism in elderly people.
  • 32. Conclusions  Subclinical thyroid disease is a common clinical problem and since most patients are asymptomatic, screening is the only way that most patients with the condition will be detected.  Recommend treatment of individuals with subclinical hyperthyroidism who are older than 65 years of age with serum TSH concentrations less than 0·1 mU/L.  Subclinical hypothyroidism who have serum TSH concentrations of 10 mU/L or more.  Pregnant women with serum TSH concentrations that are above the reference range for pregnancy.  Patients who have more mildly low or high serum TSH concentrations in between the extremes (ie, 0·1-0·5 mU/L and 5·0-10·0 mU/L), no firm recommendations and the decision to treat or not to treat a patient is based on various clinical factors.
  • 33. References  The Lancet, Volume 379, Issue 9821, Pages 1142 - 1154, 24 March 2012.  Harrisons 18th edition volume 2 pages 2911-2935.  Williams Textbook of Endocrinology,12th edition.